Dow Down 0.36% Nasdaq Down 0.53%

Actavis plc (ACT)

-NYSE
234.38 1.64(0.70%) Sep 12, 4:05PM EDT
Prev Close:232.74
Open:232.14
Bid:225.58 x 100
Ask:242.20 x 100
1y Target Est:266.95
Beta:0.35
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:231.02 - 239.15
52wk Range:135.50 - 239.15
Volume:2,612,594
Avg Vol (3m):2,307,460
Market Cap:61.94B
P/E (ttm):N/A
EPS (ttm):-3.60
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACTUp 0.70%61.94B
MYL17.60B
NVS227.48B
TEVA44.46B

Key Statistics

Forward P/E (1 yr):14.32
P/S (ttm):6.08
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :13.27
Quarterly EPS Est (Sep-14) :3.09
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):0.89

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Actavis plc, an integrated specialty pharmaceutical company, is engaged in the development, manufacture, marketing, sale, and distribution of pharmaceutical products in the Americas, Europe, the Middle East, Africa, Australia, and the Asia Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback